Multifunctional antibiotic- and zinc-containing mesoporous bioactive glass scaffolds to fight bone infection
C. Heras, J. Jimenez Holguin, A. L. Doadrio, M. Vallet-Regi, S., Sanchez-Salcedo, A. J. Salinas

TL;DR
This study develops zinc-doped mesoporous bioactive glass scaffolds loaded with antibiotics, demonstrating synergistic antibacterial effects and complete biofilm destruction, offering a promising approach for treating bone infections and combating resistance.
Contribution
The paper introduces multifunctional scaffolds combining zinc doping and antibiotic loading, with detailed physicochemical and molecular modeling analyses, showing enhanced antibacterial efficacy against bone infection pathogens.
Findings
Synergistic antibacterial effects of zinc ions and antibiotics.
Complete destruction of S. aureus and E. coli biofilms.
Effective antibiotic release and biofilm eradication on scaffolds.
Abstract
Bone regeneration is a clinical challenge that requires multiple approaches. Sometimes, it also includes the development of new osteogenic and antibacterial biomaterials to treat the occurrence of possible infection processes derived from surgery. This study evaluates the antibacterial properties of meso-macroporous scaffolds coated with gelatin and based on a bioactive glass and after being doped with 4% ZnO (4ZN-GE) and loaded with saturated and minimally inhibitory concentrations of one of the antibiotics levofloxacin (LEVO), vancomycin (VANCO), rifampicin (RIFAM) or gentamicin (GENTA). After the physicochemical characterization of the materials, inorganic ion and antibiotic release studies were performed from the scaffolds. In addition, molecular modeling allowed the determination of electrostatic potential density maps and hydrogen bonds of the antibiotics and the glass matrix. In…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
